Literature DB >> 29317913

Prevalence and risk factors for bloodstream infection present on hospital admission.

Sainfer Aliyu1, Bevin Cohen1,2, Jianfang Liu1, Elaine Larson1,2.   

Abstract

BACKGROUND: Bloodstream infection present on hospital admission (BSI-POA) is a major cause of morbidity and mortality. The purpose of this study was to measure prevalence and describe the risk factors of patients with BSI-POA and to determine the prevalence of resistance in isolates by admission source.
METHODS: We conducted a retrospective cohort study of patients discharged from three hospitals in New York City between 2006 and 2014. BSI-POA was defined as BSI diagnosed within 48 h of hospitalisation.
RESULTS: The prevalence for BSI-POA was 5307/315,010 discharges (1.7%). The odds of being admitted with BSI-POA were greatest among patients admitted with renal failure, chronic dermatitis, malignancies and prior hospitalisation. Odds ratios and 95% confidence intervals (CI) were 2.72 (95% CI = 2.56-2.88), 2.15 (95% CI = 1.97-2.34), 1.76 (95% CI = 1.64-1.88) and 1.59 (95% CI = 1.50-1.69), respectively. The largest proportion of BSI-POA presented with Staphylococcus aureus (48.4%), followed by Enterococcus faecalis/faecium (20.3%), Klebsiella pneumoniae (16.2%), Streptococcus pneumoniae (8.7%), Pseudomonas aeruginosa (4.2%) and Acinetobacter baumannii (2.2%). Overall, 44% of those admitted from nursing homes presented with antibiotic resistant strains versus 34% from other hospitals and 31% from private homes (P = 0.002).
CONCLUSION: Understanding the risk factors of patients who present to the hospital with BSI could enable timely interventions and better patient outcomes.

Entities:  

Keywords:  Bloodstream infection; community-acquired bloodstream infection; present on admission

Year:  2017        PMID: 29317913      PMCID: PMC5753947          DOI: 10.1177/1757177417720998

Source DB:  PubMed          Journal:  J Infect Prev        ISSN: 1757-1782


  28 in total

1.  Quantifying interhospital patient sharing as a mechanism for infectious disease spread.

Authors:  Susan S Huang; Taliser R Avery; Yeohan Song; Kristen R Elkins; Christopher C Nguyen; Sandra K Nutter; Alaka A Nafday; Curtis J Condon; Michael T Chang; David Chrest; John Boos; Georgiy Bobashev; William Wheaton; Steven A Frank; Richard Platt; Marc Lipsitch; Robin M Bush; Stephen Eubank; Donald S Burke; Bruce Y Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Molecular and clinical characteristics of hospital and community onset methicillin-resistant Staphylococcus aureus strains associated with bloodstream infections.

Authors:  Shu-Hua Wang; Lisa Hines; Joany van Balen; José R Mediavilla; Xueliang Pan; Armando E Hoet; Barry N Kreiswirth; Preeti Pancholi; Kurt B Stevenson
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

Review 5.  Management of multidrug-resistant enterococcal infections.

Authors:  C A Arias; G A Contreras; B E Murray
Journal:  Clin Microbiol Infect       Date:  2010-06       Impact factor: 8.067

6.  Using electronically available inpatient hospital data for research.

Authors:  Mandar Apte; Matthew Neidell; E Yoko Furuya; David Caplan; Sherry Glied; Elaine Larson
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

Review 7.  Incidence of bloodstream infection: a review of population-based studies.

Authors:  K B Laupland
Journal:  Clin Microbiol Infect       Date:  2013-02-11       Impact factor: 8.067

8.  The pattern of excess cancer in dialysis and transplantation.

Authors:  John H Stewart; Claire M Vajdic; Marina T van Leeuwen; Janaki Amin; Angela C Webster; Jeremy R Chapman; Stephen P McDonald; Andrew E Grulich; Margaret R E McCredie
Journal:  Nephrol Dial Transplant       Date:  2009-07-08       Impact factor: 5.992

9.  Early deaths in bloodstream infections: a population-based case series.

Authors:  Keiju S K Kontula; Kirsi Skogberg; Jukka Ollgren; Asko Järvinen; Outi Lyytikäinen
Journal:  Infect Dis (Lond)       Date:  2016-01-14

10.  Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis.

Authors:  Matthew T James; Kevin B Laupland; Marcello Tonelli; Braden J Manns; Bruce F Culleton; Brenda R Hemmelgarn
Journal:  Arch Intern Med       Date:  2008-11-24
View more
  5 in total

1.  Assessing burden of central line-associated bloodstream infections present on hospital admission.

Authors:  Hannah Leeman; Sara E Cosgrove; Deborah Williams; Sara C Keller
Journal:  Am J Infect Control       Date:  2019-09-09       Impact factor: 2.918

2.  Antimicrobial Susceptibility Pattern and Associated Factors of Pediatric Septicemia in Southern Ethiopia.

Authors:  Gemechu Ameya; Temesgen Weldemedhin; Tsegaye Tsalla; Feleke Gebremeskel
Journal:  Infect Drug Resist       Date:  2020-10-30       Impact factor: 4.003

3.  Bloodstream Infection Following Cardiac Valve Repair: A Population-Based Study.

Authors:  Jack W McHugh; Khawaja M Talha; Larry M Baddour; Karen M Fischer; Juan Crestanello; Arman Arghami; Daniel C DeSimone
Journal:  Open Forum Infect Dis       Date:  2021-11-18       Impact factor: 3.835

4.  Risk factors for nosocomial bloodstream infections in COVID-19 affected patients: protocol for a case-control study.

Authors:  Carla Codina-Jiménez; Sergio Marin; Marlene Álvarez; Maria Dolores Quesada; Beatriz Rodríguez-Ponga; Ester Valls; Carles Quiñones
Journal:  Eur J Hosp Pharm       Date:  2021-08-16

5.  Bacteriological profile and antibiogram of blood culture isolates from bloodstream infections in a rural tertiary hospital in Nigeria.

Authors:  Oluwalana T Oyekale; Bola O Ojo; Adewale T Olajide; Oluwatoyin I Oyekale
Journal:  Afr J Lab Med       Date:  2022-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.